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Poly(N-substituted glycine) “peptoids” are an interesting class of peptidomimics that can
resist proteolysis and mimic naturally found antimicrobial peptides (AMPs), which exhibit
wide spectrum activity against bacteria. This work investigates the possibility of modifying
peptoid AMP mimics (AMPMs) with aliphatic lipid “tails” to generate “lipopeptoids”
that can assemble into micellar nanostructures, and evaluates their antimicrobial
activities. Two families of AMPMs with different distributions of hydrophobic and cationic
residues were employed—one with a uniform repeating amphiphilicity, the other with
a surfactant-like head-to-tail amphiphilicity. To further evaluate the interplay between
self-assembly and activity, the lipopeptoids were variously modified at the AMPM chain
ends with a diethylene glycol (EG2) and/or a cationic group (Nlys-Nlys dipeptoid) to adjust
amphiphilicity and chain flexibility. Self-assembly was investigated by critical aggregation
concentration (CAC) fluorescence assays and dynamic light scattering (DLS). The
structure of a key species was also verified by small-angle X-ray scattering (SAXS)
and cryo-electron microscopy (cryo-EM). To screen for antibacterial properties, we
measured the minimum inhibitory concentrations (MIC) against S. aureus, E. coli, and P.
aeruginosa. We found that certain combinations of lipid tail and AMPM sequences exhibit
increased antibacterial activity (i.e., decreased MICs). Perhaps counter-intuitively, we
were particularly interested in increasedMICs in combination with low CACs. Concealing
antimicrobial interactions due to packing of AMPMs in nano-assemblies could pave the
way to AMPMs that may be “inert” even if unintentionally released and prevent microbes
from gaining resistance to the lipopeptoids. Overall, incorporation of EG2 significantly
improved lipopeptoids packing while the hydrophobic tail length was found to have a
major influence over the MIC. One particular sequence, which we named C15-EG2-(kss)4,
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exhibited a very low CAC of 34µM (0.0075 wt.%) and a significantly increasedMIC above
values for the unmodified AMPM. With the sequence design trends uncovered from this
study, future work will focus on discovering more species such as C15-EG2-(kss)4 and
on investigating release mechanisms and the potency of the released lipopeptoids.
Keywords: self-assembly, micelles, antimicrobial peptide, peptoids, DLS, CAC, MIC
GRAPHICAL ABSTRACT | Chain end modifications of antimicrobial peptoids embodying different lengths and conformations result in lipopeptoids with various
combinations of self-assembly and antimicrobial properties. A diethylene glycol linker and alternating cationic and hydrophobic residues are key to controlling
self-assembly.
INTRODUCTION
The past decades have witnessed a significant increase in
antimicrobial resistance (AMR) causing a large burden on
healthcare (Pendleton et al., 2013; Molchanova et al., 2017).
Antibiotic drugs have enabled modern medicine by treating
microbial infection. However, their specific mechanisms of
binding to cellular molecular targets enables bacteria to develop
resistance (Chen et al., 2014). Hence, new antimicrobials need
to be developed, especially those that exhibit different or broad-
spectrum bactericidal activity. For example, various peptides
and polymer designs have been proposed to disrupt bacterial
membranes by broadly utilizing electrostatic interactions with
subsequent pore generation (Fukushima et al., 2012; Haney
et al., 2017). Moreover, antimicrobial peptides (AMPs) expressed
by many living species as a defense mechanism against other
bacteria, fungi and viruses, have been proposed as an alternative
to antibacterial and antifungal drugs (Zasloff, 2002; Raaijmakers
et al., 2010; Zhao et al., 2017). However, peptides, especially
oligomeric species exhibiting antimicrobial activity, are prone
to biodegradation under the effect of bacterial and other
extracellular proteases. To overcome such limitations, there
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is a significant drive to generate more stable peptidomimics
(Fukushima et al., 2012; Jain et al., 2014; Molchanova et al., 2017).
Inspired by the diverse nanostructures and biofunctionality
of natural peptides, peptide amphiphiles (or lipopeptides) with
one or more lipid tails attached to an (amphiphilic) peptide head
group have been a focus of biomaterials research. Depending
on the peptide sequence and the length of the hydrophobic
“tail,” these surfactant-like molecules can self-assemble into
nanoassemblies such as micelles, nanofibrils, nanotapes, rods,
vesicles, etc., (Hamley, 2015). Demonstrations of a range of
applications in food safety and therapeutics, drug delivery, crop
protection and other biomedical applications have been reported
(De La Rica and Matsui, 2010; Zelzer and Ulijn, 2010; Hamley,
2015). However, as peptide materials, they do not address the
problem of proteolytic degradation.
Peptoids are a recently developed class of peptidomimics
(Simon et al., 1992). Their sidechains are attached to the amide
nitrogen of N-substituted glycine residues, rather than to the
backbone α-carbons as in peptides (Simon et al., 1992), thus
preventing their recognition by proteases and enabling resistance
against proteolysis. This sidechain shift also results in an achiral
backbone and preclusion of inter- and intra-backbone hydrogen
bonding, and hence backbone conformational flexibility is
enhanced (Sun and Zuckermann, 2013; Lau, 2014). Bioactivity
and formation of secondary and supramolecular structures are
therefore tailored based predominantly on side-chain sequence
selection (Czyzewski and Barron, 2008; Lau, 2014). A powerful
advantage of peptoids is the “submonomer” solid phase synthesis
approach for conveniently generating sequences with diverse
natural and non-natural sidechains (Zuckermann et al., 1992;
Lau, 2014; Lau et al., 2017). Antimicrobial and antifouling
peptoid sequences (Statz et al., 2008; Lau et al., 2012; Lohan and
Singh Bisht, 2013), anti-biofouling surfaces (Hasan et al., 2020),
applications in drug discovery (Zuckermann and Kodadek,
2009), diagnosing amyloid proteins (Luo et al., 2013), etc., have
all been reported. Peptoid self-assembly is a rapidly emerging
area, and a number of groups have reported a variety of
nanostructures, including micelles (Lau et al., 2017), nanotubes
(Jin et al., 2018), and nanosheets (Robertson et al., 2016;
Castelletto et al., 2019). However, the interplay between self-
assembly and bioactivity is still less explored.
In this work, we report the design, synthesis and
characterization of amphiphilic lipopeptoids as potential
self-assembling antimicrobials. Previous work by Findlay et al.
demonstrated the replacement of cationic lipopeptides with
lipopeptoids without affecting their antimicrobial activities
(Findlay et al., 2012). However, they did not emphasize
the self-assembly of their lipopeptoids and their bioactivity
thereafter. We have previously demonstrated the predictable
formation of ultra-small and highly stable spherical micelles
from “lipopeptoids” comprising of a lipid tail coupled to an
amphiphilic peptoid oligomer (Lau et al., 2017). We have
now generated a set of bioactive lipopeptoids by coupling
existing high-potency peptoid AMPMs (antimicrobial peptide
mimics), originally reported by the Barron (Chongsiriwatana
et al., 2008) and Hansen (Ryge and Hansen, 2005) groups,
to hydrophobic lipid tails of different lengths (i.e., C8, C11
and C15). Further insertions of ethylene glycol (EG2) at the
N-terminus of the AMPM and a pair of cationic residues at
the C-terminus were explored for controlling self-assembly
and antibacterial behavior. Self-assembly was characterized by
critical aggregation concentration (CAC) fluorescence assays
and dynamic light scattering (DLS), supplemented by cryo-
transmission electron microscope (cyro-TEM) and small angle
X-ray scattering (SAXS). Minimum inhibitory concentration
(MIC) assays against the Gram positive Staphylococcus aureus
and Gram negative Pseudomonas aeruginosa and Escherichia
coli were used to screen for changes in antimicrobial activity of
our library compared to the native AMPMs. While it may be
anticipated that specific sequences might be discovered to exhibit
enhanced antimicrobial activity and/or propensity for self-
assembly after chain end modifications, we were also interested
in discovering sequences with increased MICs above their
CACs. Such cases could indicate “packaging” of antimicrobial
sequences into inactive nanostructured delivery vehicles, which
could later be triggered for nanostructure disassembly and
release of the lipopeptoids. This could provide an approach
for preventing microbes from gaining exposure to the AMPMs
if the lipopeptoids were unintentionally released into such an
environment, thereby acquiring resistance.
MATERIALS AND METHODS
Materials
All solvents and chemicals used (including HPLC-grade
mobile phases) were purchased from Sigma-Aldrich UK, unless
otherwise specified. Rink amide MBHA resin was bought from
Merck, UK. Tert-butyl N-(4-aminobutyl) carbamate (NLys)
and (1S)-1-phenylethylamine (Nspe) monomers were purchased
from Apollo scientific, UK. Fmoc-amino-3,6 dioxaoctanoic acid
was procured from FluroChem, UK.
Lipopeptoids Synthesis
Peptoids were synthesized on resin manually or with an
automated synthesizer (Prelude X, Gyros Protein Technologies)
using a solid phase “submonomer” approach (Zuckermann et al.,
1992; Lau, 2014; Lau et al., 2017). Briefly, the Fmoc protected
rink amide resin was deprotected with 20% piperidine for
20min, applied twice. Each residue was added by treatment
to a mixture of bromoacetic acid (20 times excess) and
diisopropyl-carbodiimide (18.5 times excess) for 15min,
followed by a halo-substitution reaction with appropriate
primary amine submonomers. For the attachment of a di
ethylene glycol linker, Fmoc-amino-3,6 dioxaoctanoic acid (1.8
mmol), and equivalent moles of HBTU ((2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) were
reacted with the terminal amino group in the presence of
N,N-diisopropylethylamine (DIPEA, 2.7 mmol). This reaction
was carried out for 2 h at 37◦C and repeated a second time
for 4 h, to ensure coupling. Like resin Fmoc deprotection,
EG2 N-terminal Fmoc deprotection was achieved using 20%
piperidine for 20min, applied twice. Different chain lengths of
saturated fatty acids, i.e., pelargonic acid (C8), lauric acid (C11),
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and palmitic acid (C15) were subsequently coupled using the
HBTU amide coupling as reported previously (Lau et al., 2017).
After solid phase synthesis, the resin was cleaved and side chains
were deprotected for 30min using a standard TFA:TIPS:H2O
cocktail (95:2.5:2.5 v/v/v). Excess TFA was removed using a
rotary evaporator and the peptoid was precipitated from the
oily product using diethyl ether. The collected material was
dissolved in small amounts of 1:1 acetonitrile:water (ACN:H2O)
to ease sample transfer, and further dried in a lyophilizer.
Dried crude products were weighed and dissolved in ACN-H2O
mixtures for preparative RP-HPLC (Dionex Ultimate 3000) with
a C18 column (250 × 10mm Phenomenex Jupiter). Fractions
containing the pure product were identified by ESI-LC-MS
(Agilent 1200 with a Poroshell C18 column coupled to an Agilent
6130 mass spectrometer) and by analytical RP-HPLC (Dionex
P680) using a C18 column (250 × 4.6mm “Nucleosil”) with a
30min gradient of 5–95% acetonitrile (ACN) in water containing
0.1% TFA at 1 mL/min. The purified fractions of peptoids and
lipopeptoids were later stored as aliquots at −20◦C until further
analysis. The analytical HPLC and ESI-MS data are shown in
Figures S1–S5.
Dynamic Light Scattering (DLS) Analysis
DLSmeasurements were carried out at room temperature (25◦C)
using an ALV/LSE-5004 instrument equipped with He-Ne laser
(λ = 632.8 nm) at a detection angle of θ = 90◦ (Lau et al.,
2017). Samples were prepared at a concentration of 0.4 wt.% in
deionized water (DI) water and further filtered using 0.22µm
pore size surfactant-free cellulose acetate (SFCA) syringe filters
(Sigma Aldrich, UK) to avoid particulate contamination.
Cryogenic Transmission Electron
Microscopy (Cryo-TEM)
Sizes of selected lipopeptoid nano-assemblies were verified using
a field emission cryo-electron microscope (JEOL JEM3200FSC),
operating at 200 kV and at −187◦C, configured in bright
field mode and zero loss energy filtering (omega type) with
a slit width of 20 eV. Sizes of selected lipopeptoids nano-
assemblies were measured from photographs recorded using a
Gatan Ultrascan 4000 CCD camera. Vitrified specimens were
prepared on Quantifoil 3.5/1 holey carbon copper grids (hole
size of 3.5µm). The grids were first plasma cleaned using a
Gatan Solarus 9500 plasma cleaner and then transferred into the
environmental chamber of an automated FEI Vitrobot device at
room temperature and 100% humidity. Thereafter, 3 µL of the
sample solution was applied on the grid, which was blotted twice
for 5 s and then vitrified in a 1:1 mixture of liquid ethane and
propane at a temperature of −180◦C. The grids with vitrified
sample solution were maintained at liquid nitrogen temperature
and then cryo-transferred to the microscope.
Small Angle X-Ray Scattering (SAXS)
SAXS experiments were performed on the bioSAXS beamline
B21 at Diamond Light Source, U.K., using a previously
established protocol (Castelletto et al., 2019). Briefly, solutions
containing 1 wt.% peptoid were loaded into a set of PCR
tubes fitted in the 96-well plate of the BioSAXS robot. From
there, the robot loaded the solutions into a quartz capillary
perpendicularly placed in the path of the incident X-ray beam.
SAXS data, collected using a Dectris PILATUS 2M detector at a
fixed camera length of 3.9m, is presented as scattering intensity
vs. q = 4pi sinθ /λ (2θ: scattering angle; wavelength: λ = 1
Å). See Supplementary Information for description of SAXS
data fitting.
Critical Aggregation Concentration (CAC)
Assay
Nile red (NR) fluorescence was used to measure critical
aggregation concentration (CAC) for the synthesized
lipopeptoids. Lipopeptoids were dissolved at 2.5 × 10−2 to
1 wt.% in a dilute solution of Nile red (0.25 µg/100mL, i.e.
∼10 nM concentration) prepared in water. NR was excited at
552 nm and emission was recorded at room temperature in the
range 550–750 nm using a 10.0 × 5.0 mm2 quartz cell (Jasco
spectrofluorimeter FP-6500). The intensity of the peak centered
around 610 nm is shown in the data presented in Section results
and discussion.
Antibacterial Analysis
Minimum inhibitory concentration (MIC) analysis was
performed against Gram positive (Staphylococcus aureus (NCTC
4135), and Gram negative [Escherichia coli (ATCC 25922),
and Pseudomonas aeruginosa (PA01)] strains. Analysis was
performed in Mueller–Hinton (MH) broth using the broth
microdilution method (CLSI M07-A10) in 96 well plates (CLSI,
2015). Bacterial strains (∼5 × 105 CFU/mL) with different
concentrations of peptoids and lipopeptoids were incubated
overnight at 37◦C. Optical density (OD) was recorded at 600 nm
using a plate reader (Infinite 200 Pro, Tecan). The MIC value
(concentration for which the OD was halfway between the
minimum and maximum values) was obtained by fitting the
OD data to a sigmoidal model using Origin software, which also
computed the standard deviation. Technical triplicates (n = 3)
or more of samples at each concentration were analyzed.
RESULTS AND DISCUSSION
Design of Lipopeptoids Based on (kss)4
and 4/5k Antimicrobial Sequences
The basic peptoid design follows our earlier work that attached
a palmitic acid (C15) hydrophobic lipid tail to the N-terminus of
oligopeptoids 6–8 residues long (Lau et al., 2017). These earlier
oligopeptoids were typified by a short amphiphilic segment with
alternating hydrophobic/hydrophilic residues and a cationic,
highly soluble C-terminal Nlys-Nlys “kk” dipeptoid, inserted with
the intention to increase water solubility. Self-assembly of the
resulting lipopeptoids was strongly driven by the hydrophobic
lipid tail and the relatively bulky, but water soluble oligopeptoid.
In this study, we postulate that nano-assemblies can likewise
be formed from lipopeptoids prepared by attaching lipid tails to
the chain ends (i.e., C- and N- termini) of known antimicrobial
amphiphilic oligopeptoids (Figure 1). To investigate the scope
of this approach, we included two families of antimicrobial
peptoids (AMPMs) for modification, one reported by Barron
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FIGURE 1 | Chemical structures of (A) peptoid monomers, (B) the AMPM (kss)n, where n = 2, 3, or 4, (C) C- and N-terminal modifications of the kss family of
lipopeptoids, (D) the Nlys-rich 4k, 5k, and kykbk AMPs from Hansen’s work (Ryge and Hansen, 2005), and (E) the corresponding 4/5k family of lipopeptoids.
et al. (Patch and Barron, 2003; Chongsiriwatana et al., 2008)
and the other by Ryge and Hansen (2005). These AMPMs were
chosen not only for their demonstrated effectiveness against
a wide spectrum of bacteria but also for possessing different
distributions of amphiphilicity along their sequences. Moreover,
the two families exhibit different sequence distribution of cationic
and hydrophobic residues. Barron group’s helical AMPMs are
typified by multiple repeats of an amphiphilic Nlys-Nspe-Nspe
trimeric motif, which we designated as “kss,” with the small
letters k and s denoting Nlys and Nspe residues, respectively
(Figures 1B,C). We selected three AMPMs from the Ryge and
Hansen study consisting of several consecutive cationic Nlys
residues at the C-terminus followed by a hydrophobic segment
of similar length. The corresponding lipopeptoids are designated
as the 4/5k family since one sequence has four consecutive C-
terminal Nlys residues (4k), another has five (5k), and the third
has an alternating amphiphilic C-terminal “kykbk” sequence
(Figures 1D,E) (Ryge and Hansen, 2005).
To study how the AMPM sequences need to be balanced by
the lipid tail and other components to obtain high assembly
propensities, we included designs with different lengths of the
hydrophobic aliphatic tail (C8, C11, C15). For the kss motif we
also studied lipopeptoids with varying AMPMmotif lengths [i.e.,
(kss)n, where n = 2, 3, 4]. While longer hydrophobic tails (C8,
C11, C15) should promote assembly of hydrophobic cores, the
effect of repeating the kss motif is less clear. However, it has
been shown that longer kss sequences are more potent AMPMs
(Czyzewski and Barron, 2008). In addition, analogous to our
initial lipopeptoid report (Lau et al., 2017), we inserted the
cationic C-terminal “kk” dipeptoid with the intention of creating
a more water soluble “headgroup.” A new feature, a flexible
diethylene glycol hydrophilic linker (EG2) is introduced between
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TABLE 1 | Characteristics of antimicrobial peptoids and lipopeptoid designs tested and measured values of CAC and MIC (see sections self-assembly of kss lipopeptoids
to antibacterial MIC measurements for description).
Compound name Sequence MW CAC (µM) Antimicrobial activity
S. aureus9 (µM) E. coli* (µM) P. aeruginosa# (µM)
(kss)2 H-(Nlys-Nspe-Nspe)2-NH2 918 NA 41 ± 2 >100 44 ± 2
(kss)3 H-(Nlys-Nspe-Nspe)3-NH2 1,369 NA 2 ± 0.2 4 ± 0.2 15 ± 1
(kss)4 H-(Nlys-Nspe-Nspe)4-NH2 1,819 NA 4 ± 0.3 6 ± 0.4 16 ± 0.3
C8-EG2-(kss)2-kk CH3(CH2)7-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)2-Nlys-Nlys-NH2 1,459 200 ± 37 9 ± 1 18 ± 3 13 ± 3
C8-EG2-(kss)3-kk CH3(CH2)7-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)3-Nlys-Nlys-NH2 1,909 270 ± 30 3 ± 1 2 ± 0.3 6 ± 2
C8-EG2-(kss)4-kk CH3(CH2)7-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)4-Nlys-Nlys-NH2 2,360 290 ± 14 2 ± 0.1 2 ± 0.3 2 ± 0.4
C11-EG2-(kss)2-kk CH3(CH2)10-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)2-Nlys-Nlys-NH2 1,501 200 ± 17 7 ± 1 9 ± 1 19 ± 1
C11-EG2-(kss)3-kk CH3(CH2)10-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)3-Nlys-Nlys-NH2 1,951 310 ± 38 1 ± 0.1 3 ± 0.2 15 ± 0.4
C11-EG2-(kss)4-kk CH3(CH2)10-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)4-Nlys-Nlys-NH2 2,402 270 ± 31 2 ± 0.2 7 ± 0.1 14 ± 1
C15-(kss)4-kk CH3(CH2)14-(Nlys-Nspe-Nspe)4-NlysNlys-NH2 2,315 300 ± 25 >100 >100 >100
C15-EG2-(kss)4-kk CH3(CH2)14-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)4-Nlys-Nlys-NH2 2,458 180 ± 11 36 ± 5 44 ± 5 >100
C15-EG2-(kss)4 CH3(CH2)14-(OCH2CH2)2O)-(Nlys-Nspe-Nspe)4-NH2 2,201 38 ± 3 50 ± 1 >100 >100
4k H-(Nnme-Nmbe-Nnme-Nbut-(Nlys)4)-NH2 1,198 NA 7 ± 0.1 7 ± 0.3 19 ± 0.4
5k H-(Nnme-Nmbe-Nnme-Nbut-(Nlys)5)-NH2 1,326 NA 8 ± 0.1 7 ± 0.2 33 ± 1
Kykbk H-(Nnme-Nlys-Nmbe-Nlys-Nnme-Nlys-Nbut-Nlys)-NH2 1,198 NA 9 ± 0.4 15 ± 1 20 ± 1
C8-EG2-4k CH3(CH2)7-(OCH2CH2)2O)-(Nnme-Nmbe-Nnme-Nbut-(Nlys)4)-NH2 1,483 2500 ± 350 18 ± 3 17 ± 1 16 ± 2
C8-EG2-5k CH3(CH2)7-(OCH2CH2)2O)-(Nnme-Nmbe-Nnme-Nbut-(Nlys)5)-NH2 1,611 1600 ± 390 8 ± 0.3 74 ± 4 41 ± 2
C8-EG2-kykbk CH3(CH2)7-(OCH2CH2)2O)-(Nnme-Nlys-Nmbe-Nlys-Nnme-Nlys
-Nbut-Nlys)-NH2
1,483 1900 ± 200 2 ± 0.2 11 ± 4 15 ± 3
C15-EG2-4k CH3(CH2)14-(OCH2CH2)2O)-(Nnme-Nmbe-Nnme-Nbut-(Nlys)4)-NH2 1,581 320 ± 24 >100 >100 >100
C15-EG2-5k CH3(CH2)14-(OCH2CH2)2O)-(Nnme-Nmbe-Nnme-Nbut-(Nlys)5)-NH2 1,709 360 ± 25 >100 75 ± 10 >100
C15-EG2-kykbk CH3(CH2)14-(OCH2CH2)2O)-(Nnme-Nlys-Nmbe-Nlys-Nnme-Nlys
-Nbut-Nlys)-NH2
1,581 410 ± 32 72 ± 20 35 ± 18 >100
NA, Not Applicable; ΨNCTC 4135; *ATCC 25922; #PA01.
the AMPMand the lipid tail, since our earlier study indicated that
flexibility along the sequence could promote assembly of more
compact and stable micelles. The exact sequences, bioactivity and
self-assembly parameters (i.e., MIC and CAC) of all designs are
listed in Table 1.
Self-Assembly of kss Lipopeptoids
We first examined with a CAC assay whether coupling a
hydrophobic tail to AMPMs and inserting the kk and EG2
components is a viable design for generating self-assembling
lipopeptoids. The CAC measures the concentration above which
hydrophobic pockets (e.g., lipophilic cores of micelles) are
formed, and lower CACs indicate higher propensities of self-
assembly. In our experiments, the CAC is indicated by an
inflection in the increase in emission intensity of a lipophilic
fluorophore tracer (Nile Red) that emits more strongly when
partitioned into hydrophobic lower dielectric environments (see
Figure S6 for an example analysis).
Taking the highly potent (kss)4 sequence as a template,
we generated a Cx-EG2-(kss)4kk series of lipopeptoids, with
x = 8, 11, 15, to examine how the length of the lipidic
tail would influence the propensity of assembly. As shown in
Figure 2A, we observed CACs of 200∼220µM (a.k.a. 0.50∼0.52
mg/mL, or 0.050∼0.052 wt.%), with increasing lengths of the
hydrophobic tail corresponding to lower CACs. These CACs
are similar to the lowest values obtained in our first reports
of lipopeptoid assembly (0.03∼0.1 wt.%) (Lau et al., 2017) and
are, in fact, relatively low for lipopeptides in general. DLS
measurements of nanostructures with hydrodynamic radius (RH)
in the range of ∼40 nm (Figures 2C,D) further verified that our
basic lipopeptoids design is viable.
Interestingly, effectively doubling the hydrophobic tail length
(C8 vs. C15) only decreased CAC slightly by 10%. The
corresponding increase in molecular weight of the lipopeptoids
was from 2,361 to 2,459 g/mol, a 4% difference in mass, whereas
the corresponding RH increases from 30 to 45 nm for C8 to
C15 was statistically marginal. However, there was a significant
increase in RP-HPLC retention on a hydrophobic column
(increase from 48 to 65% ACN from C8 to C15) (Figure 3A). The
above indicate that the lipid tail was not the main determinant
of self-assembly in this system, with self-assembly being likely
determined by a combination of other components, i.e., EG2,
(kss)n motif, and the kk headgroup.
We next examined the assembly process with different lengths
of the central antimicrobial (kss)n motif (n = 2, 3), using an
intermediate C11 tail as an example (Figure 2A). In this case, the
CAC became either moderately lower (198 µM/0.29 mg/mL for
the shortest C11-EG2-(kss)2-kk) or higher (267 µM//0.52 mg/mL
for C11-EG2-(kss)3-kk) than C11-EG2-(kss)4-kk. Although there
was no apparent trend in CAC, the HPLC retention of the
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FIGURE 2 | Plots of CACs (A,B) and hydrodynamic radii (C,D) of the kss lipopeptoids studied. The left column (A,C) shows the data for increasing tail length from C8,
C11 to C15, for different lengths of the (kss)n motif, and the right column (B,D) shows the influence of the kk cationic headgroup and the EG2 linker, based on the
(kss)4 motif and a C15 tail.
FIGURE 3 | Analytical RP-HPLC results of elution off a C18 column over a
5-95% ACN gradient for the kss family of lipopeptoids. (A) The length of the
lipid tail Cx is varied: x = 8, 11, 15. (B) The length of the antimicrobial
sequence (kss)n is changed: n = 2, 3, 4. (C) The arrangement of the EG2 and
kk segments is varied. The values labeling each data point is the elution
ACN% of individual sequences.
lipopeptoids (in %ACN) did increase with increasing number of
kss motif repeats (Figure 3B). Therefore, longer (kss)n segments
could contribute to an increased ability of the lipopeptoid to
partition in a non-polar phase, as expected, but self-assembly was
mostly driven by other effects. Since the tail length was also seen
to weakly contribute, we next examined the arrangement of the
lipopeptoids’ design components.
We returned to the C15-EG2-(kss)4-kk base sequence to
examine the influence of the kk and EG2 insertions. The (kss)4
length was chosen because it has been reported to give the highest
antimicrobial activity (Chongsiriwatana et al., 2008), and we
chose the longest C15 tail because it is seen to confer the highest
propensity to self-assemble, complementing our intention to
minimize the CAC. Figure 2B shows that removing the EG2
linker to obtain C15-(kss)4-kk resulted in assembly only at a
much higher CAC of 304µM (0.71 mg/mL). On the other hand,
removing the charged kk head group to form C15-EG2-(kss)4
dramatically decreased CAC to a very low 38µM (0.075 mg/mL,
or 0.0075 wt.%; Figure S6).
The decrease in CAC with removal of kk (i.e., C15-EG2-
(kss)4) was accompanied by a greatly increased HPLC elution to
82% ACN from 65% ACN (C15-EG2-(kss)4-kk; Figure 3C) while
removing EG2 but retaining kk caused essentially no change in
the retention (66% ACN). Ordinarily, peptoids/peptides eluting
at these relatively high ACN contents would precipitate in
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aqueous buffers. This was not observed, which is consistent with
solubility of the material enabled by micellization.
Formation of nano-assemblies from C15-EG2-(kss)4 was
further confirmed byDLS observations, which here gave RH of ca.
50 nm (Figure 2D). To corroborate DLS results complementary
structural characterizations by SAXS and cryo-TEM were also
performed. SAXS indicates the presence of nano-assemblies 24±
5 nm in radius (Figure S7A and Table S1). TEM shows that some
of these assemblies actually comprise of non-compact aggregates
as small as ca. 5 nm diameter (Figure S7B). Irregularity in shape
would have contributed to relatively larger hydrodynamic sizes
measured by DLS. On the other hand, the smallest features
seen by TEM could have been missed by DLS and SAXS since
scattering signals scale significantly with particle size.
In our initial report of lipopeptoid self-assembly (Lau
et al., 2017), we speculated that bending along the lipopeptoid
backbone could enable insertion of lipid tails toward a
hydrophobic central core while allowing the amphiphilic peptoid
sequence to lie parallel to the micelles’ outer surface, with
ionizable groups facing the external aqueous environment. The
increase in CAC with removal of EG2 is consistent with this view,
since assembly would be less favorable without the EG2 linker
enhancing flexibility between the aliphatic tail and the peptoid
sequence. The much lower CAC after removing the charged
kk “headgroup” is also in agreement with the aforementioned
hypothesis, since removing this headgroup would reduce charge
repulsion between peptoids and enhance uniformity of the
micelle’s outer shell.
Self-Assembly of 4/5k Lipopeptoids
Lipopeptoids of the 4/5k family generally exhibited a lower
assembly propensity than the kss lipopeptoids, and the aliphatic
tail length had a much greater influence on their self-assembly.
Figure 4A shows that 4/5k lipopeptoids with C15 tails all
exhibited a CAC around 300∼400µM(0.50∼0.65mg/mL), while
those with C8 tails exhibited CAC at least 3-times higher (i.e.
low assembly propensity), from 1,600 to 2,500µM (2.4∼3.7
mg/mL). Accordingly, analytical HPLC showed that the much
lower CACs, associated with the longer C15 tails, were correlated
with substantially higher retention and hydrophobicity (from 67
to 78 %ACN; Figure 4B) than that exhibited by the C8 series
(from 48 to 55 %ACN). However, differences between the 4/5k
peptoid sequences appear to play a less important role in the CAC
(i.e., assembly process) at each individual tail length. Although
CAC at the C15 tail length did indeed decrease from 410 ± 32
to 320 ± 24µM according to increasing HPLC retention from
67 to 78 ACN% (counting from kykbk, 5k, to 4k), the trend at
the C8 tail length is less clear—the most hydrophobic 4k actually
resulted in the highest CAC (2,500 ± 350µM) and the kykbk
and 5k sequences generated statistically similar CAC despite
their significantly different retentions (i.e., 1,900 ± 200/1,600 ±
390µM and 48/52 %ACN for kykbk/5k).
In comparison, the tail length and the kss repeat length for
the kss family of lipopeptoids had a limited influence on the CAC
(Figures 2A,B).
A significant difference between the two families is the
distribution of hydrophobic and cationic residues along the
antimicrobial peptoid sequences. The kss sequences express
a regular repeating kss trimer motif that induces a helical
conformation placing all the cationic sidechains on one
face of this helix. In contrast, the 4/5k sequences have
a pronounced head-to-tail switch in hydrophobicity, with
many water soluble cationic Nlys residues placed toward the
C-terminus (thus no additional kk headgroup is added to the 4/5k
lipopeptoids) and multiple hydrophobic residues placed toward
the N-terminus (Figure 1D). As such, the 4/5k lipopeptoids
resemble conventional surfactants, with a defined soluble head
group and a hydrophobic tail. Indeed, it seems plausible that
the peptoid conformations within the self-assemblies would
be different between the two families, with the conventional
surfactant configuration of the 4/5k lipopeptoids allowing for
more control of the CAC via the tail length changes. These
FIGURE 4 | CAC (A) and analytical RP-HPLC (B) results of the 4/5k family of lipopeptoids with tail lengths of C8 and C15. HPLC elution was carried out using a C18
column and a 5–95% ACN gradient.
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FIGURE 5 | Schematics illustrating hypothetical differences and similarities in lipopeptoid arrangements in nano-assemblies due to different conformations and
hydrophobicity distributions. Water-soluble cationic groups on one face of helical kssn may constrain changes in hydrophobic interactions and size of
nano-assemblies, even if different lengths of lipidic tails are used (A,B). The head-tail surfactant-like 4/5k may lead to more conventional assemblies controlled by
length of lipidic tails (C,D). The low assembly propensity (high CAC) of C8-EG2-4/5k is indicated by their irregular, looser packing. The overlapping micelles illustrate
the possibility of aggregates in generating some of the large sizes measured by DLS. Different micelle morphologies may also be possible but are not shown.
differences between the overall distribution in hydrophobic
sequence regions and our hypothesis of the subsequent effects
on assembly are summarized in Figure 5. Overall, a very large
contribution of the hydrophobic tail is needed to sway the
assembly behavior, whereas differences in conformations and
hydrophobicity distributions of the two series (i.e., helical
kss, head-tail amphiphilic 4/5k series and kk head group,
flexible EG2 linker) appear to strongly contribute to the
assembly process.
Antibacterial MIC Measurements
We measured the minimum inhibitory concentration (MICs) of
our lipopeptoids for the Gram positive Staphylococcus aureus
and the Gram negative Escherichia coli and Pseudomonas
aeruginosa. The results for Cx-EG2-(kss)n-kk series are shown in
Figure 6. The bacteria here are presumed to be interacting with
individually dissolved lipopeptoids as the MICs measured are all
below the CACs obtained (Figure 2).
Three main effects were observed. First, the MICs for the
(kss)3 and (kss)4 lipopeptoids at the C8 and C11 tail lengths
were largely unchanged compared to the native unmodified
AMPM, providing evidence that these AMPMs are amenable
to chain end modifications. This opens the door to adapting
these sequences for different applications, such as the present
case of micellar self-assembly. Second, cases were observed
where the lipopeptoids can become more active (decreased
MIC). Specifically, C11-EG2-(kss)2-kk exhibited lowerMICs than
their respective native sequences against all strains tested (i.e.,
40∼50 vs. 10∼20µM). The C8-EG2-(kss)4-kk also exhibited a
slightly lower MIC against P. aeruginosa (16 vs. 5µM). Third,
the MICs at the C15 tail length increased significantly for all
strains tested.
The increase in antimicrobial activity (decrease in MIC) after
N-terminal modification for (kss)2 is interesting, as this short
length is the least effective version of the kss AMPM reported.
Addition of a lipophilic tail generates a more surfactant-like
molecule and presumably assisted in membrane interactions, an
effect that had been reported (Kapoor et al., 2011). However,
for an AMPM that already has a length suitable for membrane
interactions (i.e., the 12-mer (kss)4), addition of a lipid tail (e.g.,
C15-EG2-(kss)4-kk) did, in fact, interfere with its activity.
Figure 7 shows the effect on the MIC after removing EG2 or
kk units while maintaining the C15 tail length. It is seen that
C15-(kss)4-kk exhibited a dramatically increased MIC (lowered
activity) above 100µM for all bacteria tested, higher than for
the range observed for C15-EG2-(kss)4-kk (Figure 6), and much
higher than the 5∼16µM MICs of the native (kss)4. As such,
the EG2 linker appears to be necessary to separate the lipid tail
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FIGURE 6 | MICs against E. coli (A), P. aeruginosa. (B), and S. aureus (C)
measured for C8-EG2-(kss)n-kk lipopeptoids with increasing tail length C8,
C11, and C15, and different lengths of the (kss)n motif. Values measured for
“unfunctionalized” (kss)n peptoids are also shown. The legend in panel A
applies to all data. The error bars denote ± 1 SD (standard deviation).
Bounded boxes with an up arrow denote that no significant inhibition was
observed up to the maximum tested 100 µM—the actual MICs could be
significantly higher. Dashed lines highlight the corresponding data points in a
series.
from the (kss)4 sequence for bacterial interactions. However,
removing kk For C15- EG2-(kss)4 also caused increases in
MIC, to >100µM against both E. coli and P. aeruginosa, and
∼50µM against S. aureus. For this sequence, the CAC at 34µM
(Figure 2B) was lower than theMIC. Thus, these increasedMICs
could be an apparent effect due to packing of the AMPMs in
nano-assemblies. Future studies will be required to investigate
release mechanisms and the corresponding activities for those
assemblies at concentrations above the CAC and below the
apparent MIC.
The MICs for the 4/5k family of lipopeptoids are shown in
Figure 8. Given the results for the kss lipopeptoids, the EG2
linker was always retained. Moreover, given the very high CACs
FIGURE 7 | MICs against E. coli, P. aeruginosa, and S. aureus for (kss)4
lipopeptoids with C15 tails but without either the kk or EG2 components. The
error bars denote ± 1 SD. Bounded boxes with an up arrow denote that no
significant inhibition was observed up to the maximum tested 100 µM—the
actual MICs could be significantly higher. Dashed lines highlight the
corresponding data points in a series.
FIGURE 8 | MICs against E. coli (A), P. aeruginosa. (B), and S. aureus (C) for
4/5k lipopeptoids with C8 and C15 tails compared with the native AMPM
sequence. The error bars denote ± 1 SD. Bounded boxes with an up arrow
denote that no significant inhibition was observed up to the maximum tested
100 µM—the actual MICs could be significantly higher. Dashed lines highlight
the corresponding data points in a series.
of the 4/5k lipopeptoids, it is assumed that the interactions
observed can all be assigned to individual chains, especially for
the C8 series. Overall, no significant effect was observed after
modifying the N-terminus with the shorter C8 tail, except for the
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5k sequence against the Gram-negative E. coli and P. aeruginosa,
for which the MIC increased. Secondly, lengthening the tail to
C15 significantly increased the MIC in general, in many cases to
above 100µM. This paralleled the MIC increases for C15-EG2-
(kss)4-kk (Figure 6). At the same time, given the ability of the
C15 tail to decrease the CAC for 4/5k lipopeptoids, compared
to the C8 tails (Figure 4), it would appear that the assembly-
promoting properties of the C15-EG2 combination (Figure 2B)
also interfered, in general, with antimicrobial activity.
DISCUSSION AND CONCLUSION
This work investigates the interplay between self-assembly and
antimicrobial activity for a series of lipopeptoids based on
modifying the C- and N-terminal ends of existing AMPM
antimicrobial peptoids. The effects of coupling a diethylene
glycol “EG2” linker and lipid tails of varying lengths to the
N-terminus, and a “kk” di-Nlys cationic headgroup to the C-
terminus, were evaluated.
Lipopeptoids based on the “kss” family of helical AMPMs
exhibited low CACs, generally around 200∼400µM (0.05∼0.1
wt.%). These values are low for relatively small self-assembling
species such as our lipopeptoids and indicate a strong propensity
for self-assembly. Surprisingly, the length of the hydrophobic
tail was found to only have a slight effect on assembly, and the
solubilizing kk headgroup actually increased the CAC. However,
an EG2 greatly enhanced self-assembly, and a very low CAC of
38µM (0.0075 wt.%) was found for a C15-EG2-(kss)4 design.
For 4/5k lipopeptoids, the kk headgroup is an intrinsic part
of the antimicrobial sequence and the tail length became a
controlling influence on assembly. Although we carried out our
CAC characterization in water, fundamental thermodynamic
forces generally drive micellar systems to lower CACs (i.e.,
higher assembly propensity) in higher buffer/salt conditions.
However, instabilities resulting from uncontrolled aggregation
may result in practice (Moreira and Firoozabadi, 2010; Palladino
and Ragone, 2011).
Overall, the high assembly propensity of C15-EG2-(kss)4 could
be associated with the unconventional linking (via use of a
flexible EG2 unit) of a hydrophobic tail to a helical kss peptoid
presenting cationic sidechains segregated to one side of the helix.
We speculate that this design could enable an arrangement of
kss peptoids parallel to the surfaces of micelles overshadowing
the contribution of different lipid tail lengths to self-assembly. In
contrast, markedly different assembly properties were observed
with the head-to-tail amphiphilicity of 4/5k peptoids, which
follow the expected lipid tail length dependencies.
The antimicrobial activities of the lipopeptoids, on the other
hand, depended significantly on the hydrophobic tail length for
both the kss and 4/5k designs. Many of our lipopeptoids with
a C8 or C11 tail either preserved, or even decreased, the MICs
compared to the native sequences. However, MICs increased
significantly with a C15 tail. In evaluating activity, lowered MICs
compared to the unmodified AMPM would be of interest if
the lipopeptoid were interacting as individual molecules, as
would be the case at concentrations below the CAC. Given
the high potency of the AMPMs studied (100 ∼ 101 µM),
almost all the lipopeptoids we generated exhibited CACs (≥102
µM) above their MICs (100 ∼ 102 µM). Thus, most of our
lipopeptoids would be interacting as solubilized species in the
unassembled state.
We were also interested in increases in the MIC in
combination with a low CAC. We hypothesized that packing of
AMPMs into molecularly large nano-assemblies would interfere
with regular membrane interactions necessary for activity, and
hence induce an apparent increase in MIC. This would pave the
way to AMPMs (and analogous AMP designs) that may remain
“inert” in the environment, even if unintentionally released,
and hence prevent microbes from gaining active exposure and
developing resistance. The sequence C15-EG2-(kss)4 satisfied
these criteria, exhibiting a CAC of 38µM (0.0075 wt.%)
combined with an MIC of 40µM against the Gram-positive S.
aureus and above 100µM against the Gram-negative E. coli and
P. aeruginosa strains tested. Further physical characterization by
SAXS, TEM and DLS showed corresponding nano-assemblies
∼40 nm in radius. Based on the trends observed in the current
study, future work will be aimed at discovering more species
with properties similar to or better than C15-EG2-(kss)4, and
at investigating release mechanisms and the potency of the
released sequences.
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